# Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C

> **NCT02099604** · PHASE3 · WITHDRAWN · sponsor: **ANRS, Emerging Infectious Diseases**

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Vitamin D + Pegylated Interferon Alpha 2b + Ribavirin

## Key facts

- **NCT ID:** NCT02099604
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study objectives were considered as obsolete regarding the new AAD arrival
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099604, "Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02099604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*